Cellectis: UCART19: First In Man Proof Of Concept To Be Presented At 2015 American Society of Hematology Annual Meeting
NEW YORK--(BUSINESS WIRE)--Regulatory News:
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) today announced that Great Ormond Street Hospital (GOSH) and University College London (UCL) will present encouraging data from a first in man clinical use of UCART19, at the 57th American Society of Hematology (ASH) Annual Meeting in Orlando during the poster session.
Help employers find you! Check out all the jobs and post your resume.
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) today announced that Great Ormond Street Hospital (GOSH) and University College London (UCL) will present encouraging data from a first in man clinical use of UCART19, at the 57th American Society of Hematology (ASH) Annual Meeting in Orlando during the poster session.
Help employers find you! Check out all the jobs and post your resume.